prostate - Oncidium Foundation

RLT-Connect joins forces with Industry Leader to Fuel Cancer Treatment Donations

Oncidium Foundation and Telix Pharmaceuticals Collaborate to Enhance Access [...]

Floriane2023-10-24T09:44:53+00:00News|

The Oncidium foundation is launching 'RLT-Connect', a revolutionary platform [...]

Floriane2023-09-19T12:18:04+00:00News|

Event: International Symposium on Trends in Radiopharmaceuticals (ISTR - [...]

Floriane2023-04-19T13:38:10+00:00Events|

Event: The 38th Annual EAU Congress Date: March 10-13, 2023 [...]

Floriane2023-03-02T16:06:08+00:00Events|

Patient Management and Operationalizing Lutetium-177–PSMA-617 for Metastatic Castration Resistant Prostate [...]

Floriane2021-09-14T08:00:52+00:00News|

Cancers 2021, 13(16), 4023; https://doi.org/10.3390/cancers13164023, August 10, 2021, by Hanbo [...]

Floriane2021-09-13T14:00:57+00:00News|

VISION Trail Results Indicate Benefit of 177Lu-PSMA-617A Added to Standard [...]

Floriane2021-09-13T13:32:35+00:00News|